Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Sulfasalazine can be a valuable alternative treatment option in AA patients who are resistant to other therapeutic modalities. It acts through immunomodulatory and anti-inflammatory effects. Sulfasalazine may be prescribed as monotherapy or combined with other therapies especially corticosteroid. Approximately one quarter of AA patients treated with sulfasalazine will achieve good to excellent response. Serious adverse reactions from sulfasalazine even in longterm use or when combined with other treatments are rare. However, a close clinical and laboratory monitoring is recommended especially at the initial period of treatment.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi